Laurion Capital Management »

BioCryst Pharmaceuticals shares owned by Laurion Capital Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $919k 149k 6.18
2024-03-31 $622k 122k 5.08
2023-12-31 $801k 134k 5.99
2017-09-30 $1.1M 216k 5.24

More positions owned by Laurion Capital Management

NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Meta Platforms Cl A Call Option (META)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
United States Steel Corporation (X)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Hess (HES)
Ansys (ANSS)
Discover Financial Services (DFS)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Broadcom Call Option (AVGO)
Bridgebio Pharma (BBIO)
Bank of America Corporation (BAC)

View all positions for Laurion Capital Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals